BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 856464)

  • 1. The distribution of [3H]vinblastine in tumor and host tissues of Nb rats bearting a transplantable lymphoma which is highly sensitive to the alkaloid.
    Noble RL; Gout PW; Wijcik LL; Hebden HF; Beer CT
    Cancer Res; 1977 May; 37(5):1455-60. PubMed ID: 856464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of intrinsic sensitivity to Vinca alkaloids in xenografts of pediatric rhabdomyosarcomas.
    Houghton JA; Williams LG; Torrance PM; Houghton PJ
    Cancer Res; 1984 Feb; 44(2):582-90. PubMed ID: 6692363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinblastine and vincristine--growth-inhibitory effects correlate with their retention by cultured Nb 2 node lymphoma cells.
    Gout PW; Noble RL; Bruchovsky N; Beer CT
    Int J Cancer; 1984 Aug; 34(2):245-8. PubMed ID: 6469399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Nov; 465():1-354. PubMed ID: 12579199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced tumor oxygenation by treatment with vinblastine.
    Sersa G; Krzic M; Sentjurc M; Ivanusa T; Beravs K; Cemazar M; Auersperg M; Swartz HM
    Cancer Res; 2001 May; 61(10):4266-71. PubMed ID: 11358854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition and tissue levels of [3H]vindesine in rats.
    Culp HW; Daniels WD; McMahon RE
    Cancer Res; 1977 Sep; 37(9):3053-6. PubMed ID: 884663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of tissue concentrations of vinca alkaloids by radioimmunoassay.
    Owellen RJ; Blair M; Van Tosh A; Hains FC
    Cancer Treat Rep; 1981; 65(5-6):469-75. PubMed ID: 7237468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Energy-dependent reduced drug binding as a mechanism of Vinca alkaloid resistance in human leukemic lymphoblasts.
    Beck WT; Cirtain MC; Lefko JL
    Mol Pharmacol; 1983 Nov; 24(3):485-92. PubMed ID: 6579344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor.
    Myers CE; Young RC; Chabner BA
    Cancer Res; 1976 May; 36(5):1653-8. PubMed ID: 1268826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continued expression of vinca alkaloid resistance by CCRF-CEM cells after treatment with tunicamycin or pronase.
    Beck WT; Cirtain MC
    Cancer Res; 1982 Jan; 42(1):184-9. PubMed ID: 7198507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion of lysosomal enzymes by drug-sensitive and multiple drug-resistant cells.
    Warren L; Jardillier JC; Ordentlich P
    Cancer Res; 1991 Apr; 51(8):1996-2001. PubMed ID: 1672622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Status of nucleoprotein synthesis in hematopoietic organs in mice with primary hypothyroidism].
    Kozlov IuA; Shevtsova NM; Pleshko RI; Kurlov OV; Baĭkov AN; Novitskiĭ VV
    Vopr Med Khim; 1993; 39(1):56-8. PubMed ID: 8498073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
    Riccobene TA; Miceli RC; Lincoln C; Knight Y; Meadows J; Stabin MG; Sung C
    J Nucl Med; 2003 Mar; 44(3):422-33. PubMed ID: 12621010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between vinblastine and ionizing radiation in the mouse MO4 fibrosarcoma in vivo.
    Van Belle S; Fortan L; De Smet M; De Neve W; Van der Elst J; Storme G
    Anticancer Res; 1994; 14(3A):1043-8. PubMed ID: 8074448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacokinetics of vinblastine by continuous intravenous infusion.
    Lu K; Yap HY; Loo TL
    Cancer Res; 1983 Mar; 43(3):1405-8. PubMed ID: 6825110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic artery injection of Yttrium-90-lipiodol: biodistribution in rats with hepatoma.
    Wang SJ; Lin WY; Lui WY; Chen MN; Tsai ZT; Ting G
    J Nucl Med; 1996 Feb; 37(2):332-5. PubMed ID: 8667072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of p-Nitrobenzoic Acid (CAS No. 62-23-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 442():1-306. PubMed ID: 12595921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of WR-2721 in normal and malignant tissues of mice and rats bearing solid tumors: dependence on tumor type, drug dose and species.
    Washburn LC; Carlton JE; Hayes RL
    Radiat Res; 1974 Aug; 59(2):475-83. PubMed ID: 4371539
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetics of distribution and retention of 3H-oestradiol-17 beta in rat tissues: a comparative study with free oestradiol and after its incorporation into liposomes.
    Jehan Q; Srivasta S; Akhlaq M; Ahmad A; Setty BS
    Endokrinologie; 1982 Jul; 80(1):8-12. PubMed ID: 7173124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and animal validation of bromine-76-bromodeoxyuridine as a proliferation marker.
    Bergström M; Lu L; Fasth KJ; Wu F; Bergström-Pettermann E; Tolmachev V; Hedberg E; Cheng A; Långström B
    J Nucl Med; 1998 Jul; 39(7):1273-9. PubMed ID: 9669410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.